{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:25Z","timestamp":1707523945373},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,23]]},"DOI":"10.7759\/cureus.43980","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T14:36:07Z","timestamp":1692801367000},"source":"Crossref","is-referenced-by-count":0,"title":["The Association Between COVID-19 Mortality and ICU Admission Rates and Prior History of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use Among Hospitalized COVID-19 Patients With Hypertension in Michigan"],"prefix":"10.7759","author":[{"given":"Eiman","family":"Elhouderi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Elsawalhy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najlaa","family":"Al-Sudani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irum","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Sengstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"COVID data tracker. (2021). Accessed. 10\/01\/2021: https:\/\/covid.cdc.gov\/covid-data-tracker\/#datatracker-home."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2021.1903704","article-title":"Assessment of COVID-19 deaths from cardiological perspective","volume":"77","author":"Omar T","year":"2022","unstructured":"Omar T, Karakayal\u0131 M, Perincek G. Assessment of COVID-19 deaths from cardiological perspective. Acta Cardiol. 2022, 77:231-8. 10.1080\/00015385.2021.1903704","journal-title":"Acta Cardiol"},{"key":"ref3","article-title":"Hypertension prevalence among adults aged 18 and over: United States, 2017-2018","author":"Ostchega Y","year":"2020","unstructured":"Ostchega Y, Fryar CD, Nwankwo T, Nguyen DT. Hypertension prevalence among adults aged 18 and over: United States, 2017-2018. NCHS Data Brief. 2020, 1-8.","journal-title":"NCHS Data Brief"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou P","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, et al.. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020, 579:270-3. 10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-0455-8","article-title":"Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19","volume":"43","author":"Kai H","year":"2020","unstructured":"Kai H, Kai M. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19. Hypertens Res. 2020, 43:648-54. 10.1038\/s41440-020-0455-8","journal-title":"Hypertens Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2020-001424","article-title":"Manipulation of ACE2 expression in COVID-19","volume":"7","author":"Chaudhry F","year":"2020","unstructured":"Chaudhry F, Lavandero S, Xie X, et al.. Manipulation of ACE2 expression in COVID-19. Open Heart. 2020, 7:e001424. 10.1136\/openhrt-2020-001424","journal-title":"Open Heart"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario CM","year":"2005","unstructured":"Ferrario CM, Jessup J, Chappell MC, et al.. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005, 111:2605-10. 10.1161\/CIRCULATIONAHA.104.510461","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7010e4","article-title":"Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020","volume":"70","author":"Kompaniyets L","year":"2021","unstructured":"Kompaniyets L, Goodman AB, Belay B, et al.. Body mass index and risk for COVID-19-related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. 2021, 70:355-61. 10.15585\/mmwr.mm7010e4","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2021.03.004","article-title":"Severity of COVID-19 infection in ACEI\/ARB users in specialty hospitals: a retrospective cohort study","volume":"14","author":"Alrashed AA","year":"2021","unstructured":"Alrashed AA, Khan TM, Alhusseini NK, et al.. Severity of COVID-19 infection in ACEI\/ARB users in specialty hospitals: a retrospective cohort study. J Infect Public Health. 2021, 14:726-33. 10.1016\/j.jiph.2021.03.004","journal-title":"J Infect Public Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox J","year":"2020","unstructured":"Hippisley-Cox J, Young D, Coupland C, et al.. Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people. Heart. 2020, 106:1503-11. 10.1136\/heartjnl-2020-317393","journal-title":"Heart"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215322","article-title":"Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis","volume":"76","author":"Lee HW","year":"2021","unstructured":"Lee HW, Yoon CH, Jang EJ, Lee CH. Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis. Thorax. 2021, 76:479-86. 10.1136\/thoraxjnl-2020-215322","journal-title":"Thorax"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial","volume":"325","author":"Lopes RD","year":"2021","unstructured":"Lopes RD, Macedo AV, de Barros E Silva PG, et al.. Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial. JAMA. 2021, 325:254-64. 10.1001\/jama.2020.25864","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10217","article-title":"The association of renin-angiotensin-aldosterone system inhibitors with outcomes among a predominantly ethnic minority patient population hospitalized with COVID-19: the Bronx experience","volume":"12","author":"Adrish M","year":"2020","unstructured":"Adrish M, Chilimuri S, Sun H, Mantri N, Yugay A, Zahid M. The association of renin-angiotensin-aldosterone system inhibitors with outcomes among a predominantly ethnic minority patient population hospitalized with COVID-19: the Bronx experience. Cureus. 2020, 12:e10217. 10.7759\/cureus.10217","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/146110-the-association-between-covid-19-mortality-and-icu-admission-rates-and-prior-history-of-angiotensin-converting-enzyme-inhibitor-or-angiotensin-receptor-blocker-use-among-hospitalized-covid-19-patients-with-hypertension-in-michigan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:55:23Z","timestamp":1707508523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/146110-the-association-between-covid-19-mortality-and-icu-admission-rates-and-prior-history-of-angiotensin-converting-enzyme-inhibitor-or-angiotensin-receptor-blocker-use-among-hospitalized-covid-19-patients-with-hypertension-in-michigan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.43980","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,23]]}}}